AOS benefits from strength in its businesses and accretive acquisitions. However, a tough real estate market in China remains a concern

AOS benefits from strength in its businesses and accretive acquisitions. However, a tough real estate market in China remains a concern

CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.

AXON benefits from strength across its businesses, product introductions and complementary acquisitions. Rising costs and expenses may hurt its...

AIT benefits from strength in its businesses and accretive acquisitions. However, weakness in the OEM channel remains a concern.

CSL benefits from strength across its business, acquisitions and shareholder-friendly policies. Rising costs and expenses may hurt its profitability.

WING's investment in data-driven marketing and digital transformation position it well for future growth. However, elevated costs are a concern.

Kura Sushi's technological innovations and strategic expansion position it well for future growth. However, elevated costs are a concern.

NARI continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.

Innovations and a robust diabetes market outlook raise investors' optimism for TNDM.